CD8A and COVID-19: Contrastingly, we observed high numbers of reactive, virus‐specific CD8+ T cells after re‐stimulation with SARS‐CoV‐2 derived peptides although the same cell numbers were applied for the assays, which points toward a high bystander activation of CD8+ T cells in severe COVID‐19.